CTRI/2025/09/094189Not yet recruitingNot Applicable
TO STUDY PSYCHOSOMATIC ORIGIN OF PSORIASIS WITH ASSESSMENT THROUGH PSORIASIS AREA AND SEVERITY INDEX
DR YUG UPADHYAY1 site in 1 country50 target enrollmentStarted: October 1, 2025Last updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Psoriasis Area And Severity Index
Study Overview
Brief Summary
“This trial aims to explore the psychosomatic origin of psoriasis, focusing on the role of psychological and emotional factors in the onset and progression of the disease. Participants with psoriasis will be assessed to identify underlying psychosomatic influences contributing to their condition.The primary purpose is to evaluate the connection between psychosomatic factors and psoriasis, while also monitoring the severity and extent of skin involvement using the Psoriasis Area and Severity Index (PASI) as a standardized assessment tool.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 70.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •PATIENTS WITH CONFIRMED DIAGNOSIS OF PSORIASIS CASES OF ALL RACES AND RELIGION ARE INCLUDED CASES OF ALL SOCIOECONOMIC CONDITION ARE INCLUDED.
Exclusion Criteria
- •Cases with advanced systemic diseases will be excluded.
- •Cases with irreversible pathology will be excluded.
- •Female patients who are pregnant will be excluded.
Outcomes
Primary Outcomes
Psoriasis Area And Severity Index
Time Frame: Every 7-15 day or as per requirement of cases till 18 months
Secondary Outcomes
No secondary outcomes reported
Investigators
DR YUG UPADHYAY
ANAND HOMEOPATHIC MEDICAL COLLEGE & RESEARCH INSTITUTE
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
The Effects of Audio-Based Therapy on Anxiety in PsoriasisAnxietyNCT07390487University of California, San Francisco120
Recruiting
Phase 4
Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and AntidepressantDepressionAnxietyNCT07432815Cairo University40
Recruiting
Phase 2
Early intervention in plaque psoriasis: is bimekizumab able to delay chronic inflammation?
Prospective multicenter interventional study2024-514647-29-01Centre Hospitalier Universitaire De Nice40
Recruiting
Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic ArthritisPsoriatic ArthritisNCT07286058Takeda1,182
Not yet recruiting
Not Applicable
Assessing Psoriasis Treatment OutcomesPsoriasisNCT07391423Wake Forest University Health Sciences15